Home/Filings/4/0001209191-23-011754
4//SEC Filing

Hillan Kenneth J. 4

Accession 0001209191-23-011754

CIK 0001804591other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 5:12 PM ET

Size

5.1 KB

Accession

0001209191-23-011754

Insider Transaction Report

Form 4
Period: 2023-02-20
Hillan Kenneth
Head of Therapeutics
Transactions
  • Tax Payment

    Class A Common Stock

    2023-02-20$2.87/sh5,457$15,662191,705 total
Footnotes (1)
  • [F1]The closing price on February 17, 2023, the fair market used for the transaction date.

Issuer

23andMe Holding Co.

CIK 0001804591

Entity typeother

Related Parties

1
  • filerCIK 0001600359

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:12 PM ET
Size
5.1 KB